CORPORATES Zydus subsidiary Sentynl licenses Experimental Progeria Drug Progerinin from Korea’s PRG S&T Mar 16, 2026
STOCK MARKET Top stocks to watch today, December 24: Federal Bank, Tata Steel, GAIL, Vikran Engineering, Zydus and more Dec 24, 2025
STOCK MARKET Zydus and Lupin shares in focus today after Astellas raises Mirabegron guidance by 80% Oct 31, 2025
Zydus signs exclusive agreement with Synthon for a novel 505(B)(2) oncology product for US market Feb 12, 2025
Zydus signs strategic agreement with CVS Caremark to add Zituvio , Zituvimet and ZituvimetTM to its template formulary Jan 7, 2025
Zydus receives final approval from the USFDA for its NDA Zituvimet TM XR extended release tablets Jul 19, 2024